Dublin Core
Title
CROSS-GLOBAL STUDY ANALYSIS OF THE EFFECT OF
COVID-19
COVID-19
Subject
STUDY ANALYSIS, EFFECT OF COVID-19, PREGNANCY AND LABOR
Description
Corona Virus Disease-19 (Covid-19) was declared a world pandemic which resulted in thousands of deaths in
216 countries around the world. There are 103 million cases of Covid-19 in the world, with 57.3 million patients are
recovered and 2.24 million patients are died. Meanwhile, Indonesia has reported 1,099,687 cases, the highest in Southeast
Asia, ahead of the Philippines. In this study, we focused directly on empirical studies and related keywords on the impact
of COVID-19 on pregnancy and childbirth. Pregnant women have a higher risk of acquiring respiratory viral infections
and severe pneumonia due to physiological changes in the immune and pulmonary systems. The effects of covid-19 on
pregnancy and labor were studied and obtained contrary result, obtaining that it has no effect on the occurrence of
miscarriages in the early first trimester, pregnant women are not at a higher risk of getting COVID-19 or suffering from
more severe diseases than other adults, and no evidence on the ability of virus to be transmitted to the fetus during
pregnancy or delivery. In addition, infants and young children are also known to have only mild forms of COVID-19.
Meanwhile, other research obtained pro-results; including increased risk of obesity in early pregnancy, increased risk of
membranes premature rupture by 11% and fetal distress by 14%, increased cases of delayed presentation of patients with
ectopic pregnancy which causes increased morbidity and mortality. Furthermore, it also causes increased occurrence of
hypercoagulability, increased maternal mortality with caesarean section by 58.3%, increased maternal mortality by
vaginal delivery by 25% and premature infant mortality by 16.7%, perinatal mortality and morbidity, high risk of
experiencing preeclampsia/eclampsia especially nullipara, severe infection. In addition, studies also discovered that covid19
infection also increased the tendency of admission to intensive care unit, premature birth, risk of severe maternal
complications, neonatal complications, miscarriage, stillbirth, fetal growth restriction, FIRS, neurosensory, developmental
delay, and mental health improvement in pregnant women. In this case, the alternative management for handling COVID19
during a pandemic in pregnant and maternal women is as follows: vaccines, embryonic mesenchymal stem cells,
remdesivir, and convalescent plasma.
216 countries around the world. There are 103 million cases of Covid-19 in the world, with 57.3 million patients are
recovered and 2.24 million patients are died. Meanwhile, Indonesia has reported 1,099,687 cases, the highest in Southeast
Asia, ahead of the Philippines. In this study, we focused directly on empirical studies and related keywords on the impact
of COVID-19 on pregnancy and childbirth. Pregnant women have a higher risk of acquiring respiratory viral infections
and severe pneumonia due to physiological changes in the immune and pulmonary systems. The effects of covid-19 on
pregnancy and labor were studied and obtained contrary result, obtaining that it has no effect on the occurrence of
miscarriages in the early first trimester, pregnant women are not at a higher risk of getting COVID-19 or suffering from
more severe diseases than other adults, and no evidence on the ability of virus to be transmitted to the fetus during
pregnancy or delivery. In addition, infants and young children are also known to have only mild forms of COVID-19.
Meanwhile, other research obtained pro-results; including increased risk of obesity in early pregnancy, increased risk of
membranes premature rupture by 11% and fetal distress by 14%, increased cases of delayed presentation of patients with
ectopic pregnancy which causes increased morbidity and mortality. Furthermore, it also causes increased occurrence of
hypercoagulability, increased maternal mortality with caesarean section by 58.3%, increased maternal mortality by
vaginal delivery by 25% and premature infant mortality by 16.7%, perinatal mortality and morbidity, high risk of
experiencing preeclampsia/eclampsia especially nullipara, severe infection. In addition, studies also discovered that covid19
infection also increased the tendency of admission to intensive care unit, premature birth, risk of severe maternal
complications, neonatal complications, miscarriage, stillbirth, fetal growth restriction, FIRS, neurosensory, developmental
delay, and mental health improvement in pregnant women. In this case, the alternative management for handling COVID19
during a pandemic in pregnant and maternal women is as follows: vaccines, embryonic mesenchymal stem cells,
remdesivir, and convalescent plasma.
Creator
ERNAWATI TRI HANDAYANI, SST., M.Keb.
Publisher
IJRP.ORG
Language
INGGRIS
Type
TEXT